Eprenetapopt May Develop Into New Option for TP53-Mutant MDS
OncLive,
The addition of the experimental small molecule eprenetapopt to a standard treatment for myelodysplastic syndromes is showing…
TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Overview of attention for article published in Leukemia, January 2019
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (93rd percentile)
-
High Attention Score compared to outputs of the same age and source (86th percentile)
Mentioned by
- news
- 1 news outlet
- 11 X users
- peer_reviews
- 1 peer review site
- 2 Redditors
- video
- 1 YouTube creator
- guideline
- 4 clinical guideline sources
Readers on
- mendeley
- 167 Mendeley
- citeulike
- 2 CiteULike